AI-assisted, human-published
02/15/2025 /Funding Events
Bambusa Therapeutics Completes Oversubscribed $90M Series A Funding Round
Biotech company Bambusa Therapeutics secures $90M in oversubscribed Series A funding for development of bispecific antibodies for immunological and inflammatory disorders
AI-assisted, human-published
Latest headlines
-
-
-
Stay connected!
If you have a serious, bonafide inquiry into the VentureCapital.com or PrivateEquity.com domain names, please contact us here
©2023 VentureCapital.com